Tambus, Allyza C.
HRN: 22-34-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2022
CEFUROXIME 750MG (VIAL)
12/14/2022
12/20/2022
IVT
200mg
Q8
Pcap-c
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes